NCI Precision Medicine Study Hones in on Cancer Remission
Researchers say a non-chemotherapy treatment is causing more cancer patients to experience full remission.
A recent National Cancer Institute study shows that a new targeted therapy can help prolong the time cancer patients are in remission. Called the ViPOR regimen, the non-chemotherapy treatment shrinks tumors of those who suffer from B-cell lymphoma.
Dr. Christopher Melani, associate research physician with the Lymphoid Malignancies Branch in the Center for Cancer Research at NCI, highlights the importance of combining five therapies and administering them during a fixed cycle to maximize drug synergy and make tumors disappear.
He also shares details about the second phase of the study that is expected to take place later this year as well as how precision medicine could potentially lead to a cure for all types of cancer.
-
Dr. Christopher Melani Associate Research Physician, Lymphoid Malignancies Branch, Center for Cancer Research NCI
-
A Former CDC AI Chief’s Advice for Navigating Careers Beyond Government
Travis Hoppe discusses AI in government, career growth and bringing public-sector values into industry.
4m watch -
'One CMS' Strategy Aims to Modernize Operations, Combat Fraud
The One CMS strategy is breaking down silos, improving interoperability and expanding AI-powered services for beneficiaries.
3m read -
Health Officials Shift Cybersecurity Toward Proactive Resilience
AI-enhanced threat detection, role-based training and expanded information sharing are improving cyber preparedness across federal health.
3m read -
AI Prototype Aims to Close Feedback Gaps Driving Marine Corps Attrition
PULSE Check gives commanders near-real-time insight into unit stressors, helping leaders address retention issues before Marines leave.
19m watch
